Cvs Health (CVS) Enterprise Value (2009 - 2026)

Cvs Health (CVS) has reported Enterprise Value for 18 consecutive years, with $118.4 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Enterprise Value rose 61.38% year-over-year to $118.4 billion; the trailing twelve-month figure through Jun 2026 stood at $118.4 billion (up 61.38% YoY), and the FY2025 full-year result was $90.4 billion, up 97.73% from the prior year.
• Enterprise Value rose to $118.4 billion in Q2 2026 per CVS's latest filing, from $79.8 billion in the prior quarter.
• Across five years, Enterprise Value topped out at $121.1 billion in Q1 2022 and bottomed at $45.7 billion in Q4 2024.
• Historically, Enterprise Value has averaged $85.2 billion across 5 years, with a median of $82.3 billion in 2025.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value slumped 49.42% in 2024, then soared 97.73% in 2025.
• Over 5 years, Enterprise Value stood at $105.7 billion in 2022, then retreated by 14.47% to $90.4 billion in 2023, then plunged by 49.42% to $45.7 billion in 2024, then jumped by 97.73% to $90.4 billion in 2025, then jumped by 30.97% to $118.4 billion in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered $118.4 billion, $79.8 billion, and $90.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.